Defence Therapeutics Appoints Kwin Grauer to Its Board of Directors

Semangat Membara

Vancouver, British Columbia–(Newsfile Corp. – December 9, 2022) – Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company“), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the appointment of Mr. Kwin Grauer to its board […]